Three-arm Study to Assess Efficacy and Safety of Ianalumab (VAY736) in Patients With Active Sjogren's Syndrome
Public ClinicalTrials.gov record NCT05349214. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-blind, Placebo Controlled, 3-arm Multicenter Phase 3 Study to Assess the Efficacy and Safety of Ianalumab in Patients With Active Sjogren's Syndrome (NEPTUNUS-2)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
A randomized, double-blind, placebo controlled, 3-arm multicenter phase 3 study to assess the efficacy and safety of ianalumab in patients with active Sjogren's syndrome (NEPTUNUS-2)
Study identification
- NCT ID
- NCT05349214
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 506 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 100 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 4, 2022 (Actual)
- Primary completion
- May 13, 2025 (Actual)
- Completion
- Apr 15, 2027 (Estimated)
- Last update posted
- Jun 17, 2026
2022 – 2027
United States locations
- U.S. sites
- 23
- U.S. states
- 13
- U.S. cities
- 22
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Providence Medical Foundation | Fullerton | California | 92835 | — |
| Advanced Medical Research | La Palma | California | 90623 | — |
| Bay Area Arthritis And Osteoporosis | Brandon | Florida | 33511 | — |
| GNP Research | Cooper City | Florida | 33024 | — |
| Sarasota Arthritis Res Ctr | Sarasota | Florida | 34239 | — |
| Augusta University Georgia | Augusta | Georgia | 30912 | — |
| North Georgia Rheumatology Group | Lawrenceville | Georgia | 30046 | — |
| Clin Invest Specialists Inc | Orland Park | Illinois | 60467 | — |
| Clinic of Robert Hozman | Skokie | Illinois | 60176 | — |
| Clinical Investigation Specialists, Inc. | Wauconda | Illinois | 60084 | — |
| University of Kansas Hospital | Kansas City | Kansas | 66160 | — |
| Tufts School of Dental Medicine | Boston | Massachusetts | 02111 | — |
| Arthritis Osteoporosis Assoc of NM | Las Cruces | New Mexico | 88011 | — |
| St Lawrence Health System | Potsdam | New York | 13676 | — |
| Arthritis and Osteoporosis | Charlotte | North Carolina | 28202 | — |
| On Site Clinical Solutions Llc | Charlotte | North Carolina | 28202 | — |
| RAO Research LLC | Oklahoma City | Oklahoma | 73116 | — |
| West Tennessee Research Institute | Jackson | Tennessee | 38305 | — |
| Ramesh C Gupta MD Memphis TN | Memphis | Tennessee | 38119 | — |
| Prolato Clinical Research Center | Houston | Texas | 77054 | — |
| First Outpatient Research Unit | San Antonio | Texas | 78229 | — |
| Advanced Rheumatology of Houston | Spring | Texas | 77382 | — |
| Arthritis Northwest PLLC | Spokane | Washington | 99216 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 123 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05349214, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 17, 2026 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05349214 live on ClinicalTrials.gov.